Genmab A/S (GMAB)
NASDAQ: GMAB · IEX Real-Time Price · USD
27.75
+0.51 (1.87%)
Jul 19, 2024, 4:00 PM EDT - Market closed
Genmab Employees
Genmab had 2,204 employees as of December 31, 2023. The number of employees increased by 544 or 32.77% compared to the previous year.
Employees
2,204
Change (1Y)
544
Growth (1Y)
32.77%
Revenue / Employee
$1,166,344
Profits / Employee
$357,920
Market Cap
18.08B
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 2,204 | 544 | 32.77% |
Dec 31, 2022 | 1,660 | 448 | 36.96% |
Dec 31, 2021 | 1,212 | 431 | 55.19% |
Dec 31, 2020 | 781 | 233 | 42.52% |
Dec 31, 2019 | 548 | - | - |
Sources: Annual number of employees according to filings submitted to the U.S. Securities and Exchange Commission (SEC). Data is also manually gathered from company press releases, IPO filings, and other official sources.
Related Stocks
Company Name | Employees |
---|---|
Labcorp Holdings | 67,000 |
Baxter International | 60,000 |
Teva Pharmaceutical | 37,851 |
Align Technology | 21,610 |
The Cooper Companies | 15,000 |
Illumina | 13,360 |
BeiGene | 10,600 |
Waters | 7,900 |
GMAB News
- 5 days ago - Genmab Announces Net Sales of DARZALEX® (daratumumab) for Second Quarter of 2024 - GlobeNewsWire
- 24 days ago - Epcoritamab (TEPKINLY®) Receives Positive CHMP Opinion for the Treatment of Adults with Relapsed/ Refractory Follicular Lymphoma - Business Wire
- 24 days ago - Completion of Share Buy-back Program - GlobeNewsWire
- 25 days ago - EPKINLY® (epcoritamab-bysp) Approved by U.S. FDA for Patients with Relapsed or Refractory (R/R) Follicular Lymphoma (FL) - Business Wire
- 27 days ago - Transactions in Connection with Share Buy-back Program - GlobeNewsWire
- 4 weeks ago - Capital Increase in Genmab as a Result of Employee Warrant Exercise - GlobeNewsWire
- 5 weeks ago - Grant of Restricted Stock Units and Warrants to Employees in Genmab - GlobeNewsWire
- 5 weeks ago - Transactions with shares and linked securities in Genmab A/S made by managerial employees and their closely associated persons - GlobeNewsWire